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Abstract
Background: Prior studies suggest being overweight may be protective against poor functional outcomes in older adults.
Methods: Body mass index (BMI, kg/m2) was measured over 25 years across five visits (1987–2011) among Atherosclerosis Risk in Communities 
Study participants (baseline Visit 1 n = 15,720, aged 45–64 years). Gait speed was measured at Visit 5 (“late-life”, aged ≥65 years, n = 6,229). 
BMI trajectories were examined using clinical cutpoints and continuous mixed models to estimate effects of patterns of BMI change on gait 
speed, adjusting for demographics and comorbidities.
Results: Mid-life BMI (baseline visit; 55% women; 27% black) was associated with late-life gait speed 25  years later; gait speeds were 
94.3, 89.6, and 82.1 cm/s for participants with baseline normal BMI (<25), overweight (25 ≤ BMI < 30), and obese (BMI ≥ 30) (p < .001). 
In longitudinal analyses, late-life gait speeds were 96.9, 88.8, and 81.3 cm/s for participants who maintained normal, overweight, and obese 
weight status, respectively, across 25 years (p < .01). Increasing BMI over 25 years was associated with poorer late-life gait speeds; a 1%/year 
BMI increase for a participant with a baseline BMI of 22.5 (final BMI 28.5) was associated with a 4.6-cm/s (95% confidence interval: −7.0, 
−1.8) slower late-life gait speed than a participant who maintained a baseline BMI of 22.5.
Conclusion: Being overweight in older age was not protective of mobility function. Maintaining a normal BMI in mid- and late-life may help 
preserve late-life mobility.
Keywords: Mobility—Overweight—Longitudinal
Poor mobility leads to disability, institutionalization, increased health 
care expenditures, and mortality in older adults (1–5). Obesity is a 
modifiable risk factor and therefore a feasible target for interventions. 
Growing numbers of overweight and obese persons combined with 
growing numbers of older adults in the population could result in dra-
matic increases in mobility and functionally impaired older persons (6). 
Recognizing and intervening upon early, modifiable contributors to dis-
ability could substantially reduce the associated public health burden.
However, the relationship between obesity and mobility in older 
adults is complex. Poor mobility and functional status have been 
associated with low body mass index (BMI) and with weight loss in 
older adults (7–10), and also with higher mid-life adiposity (11–16). 
It has been suggested that overweight is potentially protective in 
older adults (17). Clarity regarding the effects of body weight on 
mobility in older adults is needed to identify at-risk individuals and 
to develop interventions targeting risk factors, for example, excess 
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weight, weight loss, or underlying conditions. An older adult with a 
normal BMI could be at risk for functional impairment if underly-
ing conditions are contributing to unintentional weight loss, whereas 
another with the same BMI that has been maintained across the life 
span could have excellent function and minimal risk. Thus, failure 
to consider effects of historical changes in adiposity in addition to 
current weight may result in inaccurate risk assessments of adiposity 
on functional outcomes.
Furthermore, despite a higher prevalence of physical disability 
and mobility impairments in blacks compared with whites (18) and 
evidence that obesity exposures may differentially affect function in 
whites and non-whites (19), most studies of mobility lack substantial 
representation by non-white populations (15–17,20,21). This study 
examined the relationship of mid-life BMI and changes in BMI from 
mid- to late-life with late-life gait speed in a large, biracial prospec-
tive cohort study.
Methods
Population
The Atherosclerosis Risk in Communities (ARIC) Study is a lon-
gitudinal study of cardiovascular disease in community-dwelling, 
middle-aged adults (baseline: 1987–1989, n = 15,792, 45–64 years) 
selected through probability sampling from four U.S.  communi-
ties: Forsyth County, NC; Jackson, MS (exclusively black partici-
pants); Minneapolis, MN; and Washington County, MD. The cohort 
underwent four triennial examinations and a fifth examination in 
2011–2013 (Visit 5, n = 6,538). Due to small numbers, blacks at MN 
and MD (n = 24) and non-black, non-white participants (n = 48) 
were excluded. Another 25 did not have baseline BMI data, leaving 
15,695 with Visit 1 BMI data, of whom 6,229 had Visit 5 gait speed 
measured. All participants provided informed consent, and institu-
tional review boards of each field center approved protocols.
Gait Speed Assessment
At Visit 5, gait speed (cm/s), the preferred measure of mobility and a 
crucial vital sign of health in older adults (1,22), was measured using 
a standardized protocol (2,3) across sites. Participants were timed 
walking 4 m at their usual pace. The faster of the two trials was 
used. Walking aids were allowed if participants felt unsafe without 
them. A 10-cm/s slower gait speed is associated with a 12% higher 
mortality in older adults (5), and 4–5 cm/s is considered a meaning-
ful change (23).
Obesity Assessment
Height to the nearest centimeter, and weight, using a beam bal-
ance scale, was measured with participants wearing light clothes 
and no shoes. BMI (kg/m2) was classified using clinical cutpoints: 
<25 = Normal; 25 to <30 = Overweight; and ≥30 = Obese.
Covariates
Potential confounders included self-reported age, race/ethnicity, sex, 
education (<high school, high school graduate, or ≥college), smoking 
status, and alcohol use. Variables were constructed to define race-site 
and antihypertensive medication use, diabetes, coronary heart dis-
ease (CHD), and systolic and diastolic blood pressure. Diabetes was 
defined as self-reported use of hypoglycemic medications or fasting 
glucose ≥140 mg/dL. CHD was defined as self-report of myocardial 
infarction, cardiac bypass surgery or angioplasty, and adjudication of 
clinical findings (24) based on electrocardiograms, annual surveillance, 
medical records, annual telephone follow-up, and death certificates.
Statistical Analysis
Fisher’s exact and Kruskal–Wallis tests were used for categorical and 
continuous characteristic bivariate associations with BMI categories 
at Visit 5.
Cross-temporal associations of BMI with gait
Associations of gait speed with BMI categories at each visit were 
examined. Nonlinear relationships with continuous BMI at each 
visit were modeled using piecewise linear splines with knots at 25 
and 30 kg/m2; coefficients represent the difference in gait speed per 
5-unit increase in BMI within a BMI category. Models were adjusted 
for age, sex, race-site, education, systolic and diastolic blood pres-
sure, diabetes, antihypertensive medications, smoking, alcohol use, 
and CHD; covariate sets were updated at each visit.
Longitudinal BMI trajectory associations with gait
Up to five BMI measures across 25 years were available for each partici-
pant (Figure 1). A two-phase analytic framework was used with linear 
mixed models for longitudinal BMI trajectories in Phase 1; resulting 
subject-specific empirical-Bayes estimates were associated with univari-
ate gait speed using linear regression models in Phase 2. Three BMI 
trajectory effects were identified: (i) baseline BMI, (ii) 0–10 year %BMI 
change (Visit 1 to Visit 4), and (iii) 10–25 year %BMI change (Visit 
4 to Visit 5). BMI change groups were defined using a 5% window 
compared with the previous BMI. A 5% change in BMI approximates a 
clinically important 5% weight change in older adults (25), and ±2.5% 
approximates the ±3% BMI definition of weight maintenance (26). 
Longitudinal BMI trajectory groups were defined using the baseline BMI 
group, 0- to 10-year BMI change (maintained/increased/decreased) and 
10- to 25-year BMI change (maintained/increased/decreased), resulting 
in 27 (3 × 3 × 3) trajectory groups. Linear models were used to assess 
associations of BMI trajectory groups with gait speed. Additionally, 
nonlinear relationships with continuous BMI trajectories were mod-
eled using three-way interactions of fractional polynomial functions of 
the primary BMI effects (Baseline BMI, 0- to 10-year %-change, 10- to 
25-year %-change), using identical adjustment variables in all models. 
(See additional details and sensitivity analyses with visit-specific inverse 
proportional weights to account for deaths and dropouts, full joint 
modeling and bootstrap approaches in Supplementary Material.)
Results
Obese Visit 5 participants tended to be younger, had poorer health 
profiles, and were more likely to report black race and lower educa-
tion compared with those with normal BMI (Table  1). Exceptions 
Figure 1. Visit 1 histogram of body mass index (BMI) (left) and distribution of 
BMI at each visit. The dashed line is the mean BMI across the study period. Solid 
lines depict four exemplary individual BMI trajectories from Visit 1 to Visit 5.
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were higher total and LDL cholesterol in the normal BMI group, 
although more obese participants used statin medications. Gait speed 
was good (≥100 cm/s) (22) in 38% and poor (<60 cm/s) in 7% of the 
participants (Supplementary Table 1). Those with slower gait speeds 
were older, had lower education, and were more likely to be women 
and of black race. Compared with participants who died before Visit 
5, Visit 5 participants were younger at the baseline visit, had lower 
BMI and blood pressure, were more likely to be white, and were less 
likely to have diabetes or hypertension (Supplementary Table 1).
Cross-Temporal Relationships of BMI and Late-Life 
Gait Speed
Higher mid-life BMI was associated with slower late-life gait speeds, 
even at the earliest visit (approximately 25  years earlier) (Table  2). 
Compared with participants with normal baseline BMI, gait speed was 
12 cm/s slower in the baseline obese group (94.3 vs 82.0 cm/s, differ-
ence = −12.3 [95% CI: −14.1, −10.5]) and nearly 5 cm/s slower among 
the overweight group (94.3 vs 89.6 cm/s, difference = −4.7 [95% CI: 
−6.1, −3.3]). Differences in gait speeds across Visit 5 BMI categories 
were attenuated but remained statistically significant for the over-
weight (β = −2.7 cm/s [95% CI: −4.0, −1.4]) and obese (β = −9.8 cm/s 
[95% CI: −11.2, −8.3]) groups compared with those with normal BMI.
Nonlinear cross-sectional associations of continuous BMI with 
gait speed were most apparent at Visit 5 (Supplementary Figure 1) and 
are reported as the slopes in Table 2 from linear spline models at each 
visit. Gait speed in late-life was approximately 5 cm/s slower per 5-unit 
increase in BMI among those with normal (β = −5.4 [95% CI: −8.1, 
−2.8]) and overweight BMI (β = −4.6 [95% CI: −6.7, −2.5]) at baseline 
(mid-life), and nearly 7 cm/s slower among baseline obese participants 
(β = −6.9 [95% CI: −8.5, −5.2]). Late-life gait speed was also negatively 
associated with higher late-life BMI in the overweight BMI and obese 
BMI groups. The association of gait speed with late-life BMI (Visit 
5) within the normal BMI group was markedly attenuated and no longer 
clinically or statistically significant (β = −0.7 [95% CI: −1.6, 3.0]).
Relationships of BMI Trajectories From Mid-Life With 
Late-Life Gait Speed
BMI distributions at each visit, the mean population BMI trajec-
tory, and four individual trajectories are illustrated in Figure  1. 
Most BMI changes were within ±15% and were primarily increases 
(Supplementary Figure 2). Participants whose BMI increased in Years 
0–10 and again in Years 10–25 included 49% of those with normal 
baseline BMI, 45% of baseline overweight participants, and 37% with 
baseline obese BMI. Table 3 depicts expected gait speeds for the longi-
tudinal BMI trajectory classes, illustrating the impact of mid-life BMI 
on late-life gait speed. The impacts of baseline BMI and trajectories of 
BMI on gait speed are further illustrated in Figure 2. Trajectories over 
Years 0–10 are represented by colored lines representing specific percent 
changes in BMI. BMI changes in Years 10–25 are shown on the x-axis. 
Both maintaining higher BMI and increasing BMI were associated with 
poorer gait speed compared with maintaining BMI, especially a normal 
BMI. For example, compared with maintaining a BMI of 22.5 across 
all years, the same baseline BMI with increases of 10% in Years 0–10 
and another 10% in Years 10–25 was associated with slower late-life 
Table 1. Visit 5 Population Characteristics by Visit 5 Body Mass Index Category
Visit 5 BMI (kg/m2) Category
V5 Characteristics Total (N = 6,229)
BMI < 25 25 ≤ BMI < 30 BMI ≥ 30 
p Valuen = 1,621 (26%) n = 2,449 (39%) n = 2,159 (35%)
Age (years) 75.6 (5.2) 76.4 (5.4) 75.9 (5.3) 74.6 (4.7) <.001
Women 3,647 (59%) 1,040 (64%) 1,299 (53%) 1,308 (61%) <.001
Black 1,473 (24%) 276 (17%) 521 (21%) 676 (31%) <.001
Site-race
 Forsyth-Black 97 (2%) 18 (1%) 39 (2%) 40 (2%) <.001
 Jackson-Black 1,376 (22%) 258 (16%) 482 (20%) 636 (29%)
 Forsyth-White 1,292 (21%) 441 (27%) 523 (21%) 328 (15%)
 Minneapolis-White 1,829 (29%) 518 (32%) 750 (31%) 561 (26%)
 Washington-White 1,635 (26%) 386 (24%) 655 (27%) 594 (28%)
Education
 <High school 913 (15%) 174 (11%) 357 (15%) 382 (18%)
 High school 2,577 (41%) 658 (41%) 1,003 (41%) 916 (43%) <.001
 College 2,728 (44%) 786 (49%) 1,085 (44%) 857 (40%)
Hypertension 4,595 (75%) 1,006 (63%) 1,804 (74%) 1,785 (83%) <.001
Diabetes 2,000 (33%) 269 (17%) 737 (31%) 994 (47%) <.001
Systolic blood pressure (mmHg) 131 (18.4) 131 (19) 131 (18.0) 130 (18.4) .512
Diastolic blood pressure (mmHg) 67 (10.7) 65 (10.8) 67 (10.5) 68 (10.7) <.001
Total cholesterol (mg/dL) 181.4 (42.0) 189.9 (41.0) 181.0 (42.8) 175.5 (40.7) <.001
HDL cholesterol (mg/dL) 52.2 (14.0) 59.0 (15.6) 51.3 (13.2) 48.1 (11.4) <.001
LDL cholesterol (mg/dL) 104.2 (34.7) 109.3 (33.5) 104.5 (35.5) 100.0 (34.3) <.001
Statin use 3,183 (51%) 671 (42%) 1,338 (55%) 1,174 (55%) <.001
Current smoker 357 (6%) 145 (9%) 124 (5%) 88 (4%) <.001
Drinking status
 Current 2,928 (49%) 820 (53%) 1,223 (52%) 885 (43%)
 Former 1,755 (29%) 390 (25%) 653 (28%) 712 (34%) <.001
 Never 1,292 (22%) 327 (21%) 484 (21%) 481 (23%)
Coronary heart disease 901 (15%) 206 (13%) 405 (17%) 290 (14%) .001
Note: BMI = body mass index.
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gait speeds (final BMI = 22.5 vs 27.2: 96.8 vs 94.9 cm/s, p < .0001) 
(Figure 2A). The difference in gait speed was greater and more clini-
cally meaningful comparing a maintained BMI of 22.5 to maintaining 
a BMI of 27.5 (96.8 vs 92.2 cm/s, p < .0001) (Figure 2B). Maintaining 
an obese BMI, for example, 32.5 across all Years 0–25 (Figure 2C) was 
associated with a 10.8-cm/s difference in gait speed (96.8 vs 86.0 cm/s, 
p < .0001). BMI increases were associated with additive effects on gait 
speed; maintaining a BMI of 27.5 across all years was associated with 
a nearly 5-cm/s faster gait speed compared with a mid-life BMI of 27.5 
with a 10% increase in Years 0–10 and 10% increase in Years 10–25, 
that is, a late-life BMI of 33.2 (92.2 vs 87.4 cm/s, p < .0001).
We examined potential lasting effects of mid-life obesity, inde-
pendent of subsequent weight loss, using conservative weight loss 
percentages. Compared with maintaining a BMI of 22.5, a par-
ticipant with a mid-life BMI of 27.5 and a 10% decrease during 
Years 0–10 followed by maintenance (BMI = 24.6) in Years 10–25 
had slower gait speeds (96.8 vs 91.2 cm/s, p = .03). A similar pat-
tern of greater magnitude was observed for baseline obese partici-
pants (BMI  =  32.5) who experienced a 10% decrease in BMI in 
Years 0–10 followed by maintenance of BMI in Years 10–25 (96.8 
vs 83.7  cm/s, p < .0001). Comparing maintenance of obese BMI 
with temporary increases in BMI followed by decreases suggested 
modest, lasting effects of BMI increases on late-life gait speed; for 
example, gait speeds were better among those maintaining a BMI 
of 32.5 compared with those with the same baseline BMI and 10% 
increases in Years 0–10 then 10% decreases in Years 10–25, despite 
having the same late-life BMI (86.0 vs 83.3 cm/s, p = .02). Similar 
effects were seen comparing maintenance of an overweight BMI of 
27.5 to a baseline BMI of 27.5 followed by a 10% increase then 
10% decrease in BMI (92.2 vs 89.0 cm/s, p = .006).
Small numbers of participants experienced BMI decreases, par-
ticularly in Years 0–10, limiting precision of estimates for those with 
10% BMI decreases in Years 0–10 (Figure  2 and Supplementary 
Figure 2). Decreases in late-life BMI (Years 10–25) were more com-
mon, but were not generally associated with better gait speed. For 
example, a 10% BMI decrease in late-life for a participant who 
maintained a baseline BMI of 27.5 through Years 0–10 was asso-
ciated with statistically but not clinically worse gait speed than a 
participant who maintained a BMI of 27.5 across all years (90.0 vs 
92.2 cm/s, p = .002). Interactions between adiposity and race or sex 
were not strongly supported; there was less support among black 
men which may have been due to small numbers and lack of power.
Sensitivity analyses excluding underweight participants (BMI < 
18.5: Visit 1: n = 141; Visit 2, n = 131; Visit 3, n = 106; Visit 4, n = 90; 
and Visit 5, n = 70) yielded similar estimates with the same substan-
tive interpretation (Supplementary Table 2). Adjudicated stroke data 
were not available at Visit 1 or 5; sensitivity analyses adjusting for 
stroke at Visits 2–4 also showed similar or larger effect sizes and did 
not change the substantive interpretation (Supplementary Table 3).
Discussion
These findings dispute suggestions that being overweight in older age is 
protective of mobility. In this study, an older adult who maintained a nor-
mal BMI from mid-life would have a nearly 5-cm/s faster gait speed than 
an older adult who maintained an overweight BMI and nearly 11 cm/s 
Table 3. Gait Speed Estimates for BMI and Difference in Gait Speed by 25-Year Trajectory Groups Compared With the Group that Main-
tained Normal BMI 
25-Year BMI Trajectory Group Visit 5 Gait Speed Adjusted Differences
Group Baseline BMI 0–10 Years 10–25 Years Estimate 95% CI p Value
1  “Normal” < 25 kg/m2  
n = 5,187 (33%)
Loss > 2.5% Loss > 2.5% 90.0 −6.93 −15.49, 1.62 .112
2 Maintain 93.0 −3.89 −14.33, 6.54 .465
3 Gain > 2.5% 94.4 −2.46 −11.19, 6.27 .581
4 Maintain Loss > 2.5% 95.1 −1.82 −7.58, 3.93 .535
5 Maintain 96.9 Reference
6 Gain > 2.5% 95.2 −1.74 −7.55, 4.08 .559
7 Gain > 2.5% Loss > 2.5% 93.5 −3.38 −8.51, 1.76 .197
8 Maintain 94.6 −2.35 −7.52, 2.81 .372
9 Gain > 2.5% 94.1 −2.83 −7.80, 2.13 .263
10  “Overweight” 25–30 kg/m2 
n = 6,172 (39%)
Loss > 2.5% Loss > 2.5% 88.4 −8.49 −16.44, −0.53 .037
11 Maintain 92.9 −3.99 −11.31, 3.33 .285
12 Gain > 2.5% 88.2 −8.67 −17.09, −0.26 .043
13 Maintain Loss > 2.5% 89.7 −7.19 −12.93, −1.45 .014
14 Maintain 88.5 −8.44 −14.33, −2.54 .005
15 Gain > 2.5% 89.5 −7.44 −13.06, −1.82 .009
16 Gain > 2.5% Loss > 2.5% 90.6 −6.32 −11.32, −1.32 .013
17 Maintain 89.2 −7.73 −12.79, −2.68 .003
18 Gain > 2.5% 89.2 −7.66 −12.59, −2.73 .002
19  “Obese” ≥ 30 kg/m2  
n = 4,336 (28%)
Loss > 2.5% Loss > 2.5% 83.3 −13.62 −21.10, −6.14 <.001
20 Maintain 90.6 −6.32 −14.85, 2.20 .146
21 Gain > 2.5% 80.8 −16.12 −27.92, −4.32 .007
22 Maintain Loss > 2.5% 82.5 −14.43 −20.49, −8.37 <.001
23 Maintain 81.4 −15.53 −22.66, −8.40 <.001
24 Gain > 2.5% 82.6 −14.27 −21.42, −7.12 <.001
25 Gain > 2.5% Loss > 2.5% 81.5 −15.36 −20.68, −10.05 <.001
26 Maintain 83.4 −13.47 −19.08, −7.86 <.001
27 Gain > 2.5% 80.6 −16.26 −21.77, −10.74 <.001
Note: BMI = body mass index; CI = confidence interval. Values in bold represent participants who maintained a BMI within 2.5% of the previous BMI.
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faster than an older adult who maintained an obese BMI. The effects of 
adiposity were clinically meaningful and were greater with higher and 
longer periods of exposures, and mid-life exposures appeared to have 
lasting adverse effects on mobility that were exacerbated by weight gain.
Weight loss, low adiposity, and even normal adiposity are cited 
risk factors for poor functional status and mortality in older adults 
(17), contributing to speculation that overweight is protective in 
older age (17,27). Although the current findings did not support 
associations of weight loss in late-life with better mobility, weight 
loss in observational studies combines effects of intentional and 
unintentional weight loss (28) despite the two having differential 
associations with mortality (29). Unintentional weight loss can occur 
due to underlying disease such as cancer, heart and lung disease, and 
dementia which are associated with poor functional outcomes and 
mortality (30,31). Intentional weight loss through lifestyle interven-
tions in older adults leads to better physical function measures (32). 
Our finding of statistically different and slower gait speeds associ-
ated with late-life BMI decreases is not clinically meaningful and 
likely represents the aggregate of negative effects of unintentional 
with beneficial effects of intentional weight loss.
Our findings expand upon studies that relied on recall of mid-life 
weights (12–16,33) by using repeated anthropometric measurements 
across 25  years, reflecting the mid- to late-life transition, as well as 
objective mobility measures that many prior studies lacked. Objective 
measures improve obesity and physical function classification due to 
underreporting of weight, overreporting height (34), and overestimation 
of function (35). Our findings align with two studies that incorporated 
historical adiposity measures; one reported a deleterious relationship of 
measured mid-life adiposity and late-life physical function (16) and the 
other reported that sustained overweight at two time points 36 years 
apart in men was associated with risk for disability (36). Men who 
maintained normal weight or gained weight had similar disability, frailty, 
and mortality outcomes. Together these and our study support a need 
for early, ongoing weight management to help preserve late-life function.
Self-reported weight loss from mid-life to older age among persons 
of normal weight in mid-life has been associated with increased risk for 
disability in late-life, although not after accounting for comorbidities 
(8). Weight loss in a prior ARIC study using self-recalled weights was 
also not associated with self-reported mid-life functional status (13). 
In the National Health and Nutrition Examination Survey, mid-life 
BMI more than 27 was associated with self-reported mobility disabil-
ity in white women, but weight loss was only associated with mobility 
disability among the oldest (mean age 80 years) (9). Inconsistencies of 
our findings with prior studies could be explained by the younger age 
of the ARIC cohort in the earlier study and more sensitive measures of 
weight and mobility in the current study (3,34,35).
Proposed mechanisms whereby adiposity could affect mobility 
include mechanical effects on joints, intermuscular fatty infiltra-
tion (24), weakness (21), and associated conditions such as diabetes 
(37). Excess adipose also results in dysregulated adipocytes, meta-
bolic derangements, and inflammation that could affect nerves and 
muscles (38). By contributing to diabetes and hypertension, obesity 
could lead to ischemic brain changes that impair central control of 
mobility. However, our findings were robust to adjustments for dia-
betes and other comorbidities and when participants with a cancer 
diagnosis at Visit 5 were excluded.
Some limitations include a lack of information on arthritis, a 
probable mediator in the obesity–mobility relationship. Mediators 
should attenuate relationships but would not diminish the impor-
tance of our findings. Unintentional weight loss history was not 
available. However, weight loss in a large observational study of 
older adults was most often unintentional (28), which is associated 
with risk for adverse outcomes and likely negates beneficial influ-
ences of intentional weight loss on mobility. Muscle strength could 
negate effects of adiposity (21), and higher than expected muscle 
mass could misclassify obesity using BMI. We conducted additional 
analyses that adjusted for grip strength, which was only available at 
Visit 5, with similar results. Lastly, a single mobility assessment has 
been conducted in ARIC, limiting analyses to persons who returned 
for the exam. Those who did not return had higher baseline BMI, so 
current findings likely underestimate relationships.
Maintaining a normal BMI from mid- to late-life is associated 
with better mobility in older age, challenging the view that being 
overweight in old age has protective influences on mobility. Our 
findings make clear that assessment of adiposity risk in older age 
should incorporate prior weight histories and that prevention of 
mobility impairments in older adults may be most effective if imple-
mented and maintained in mid-life, and perhaps earlier.
Supplementary Material
Supplementary data are available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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Figure 2. Model estimates of Visit 5 gait speeds (y-axis) for participants with 
different baseline body mass index (BMI) values, by BMI changes in Years 
0–10 and BMI changes in Years 10–25. Years 10–25 BMI changes (%) are 
shown on the x-axis. Colored lines represent BMI changes (%) in Years 0–10: 
10% decrease (black line (blue line online)), 0% change (gray line (green 
line online)), 10% increase (light gray line (orange line online)), and 15% 
increase (red line). (A) Baseline BMI = 22.5 kg/m2, (B) Baseline BMI = 27.5 kg/
m2, (C) Baseline BMI = 32.5 kg/m2, and (D) Baseline BMI = 37.5 kg/m2.
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